APPLICATIONS PUBLISHED 14 APRIL 2004
Published: 1-Oct-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Method for producing articles consisting of polymer materials having a medicamentous depot effect
Veritas 1406590*
Pharmaceutical compsn for nasal delivery of estradiol and norethisterone
Les Laboratoires Servier 1406591*
A salt/ion pair medicinal aerosol formulation
Aeropharm Technology 1406592*
Biodegradable polymer compsns, compsns and uses thereto
Johns Hopkins University School of Medicine 1406593*
Controlled agglomeration
LifeCycle Pharma 1406594*
Chewable product including active ingredient
WM Wrigley Jr Company 1406595*
Zero order controlled drug delivery system
Phoqus Pharmaceuticals 1406596*
Controlled drug delivery system providing variable release rates
Phoqus Pharmaceuticals 1406597*
Lymphatic drug delivery system
Glaxo Group 1406598*
Cosmetic and dermatological preparations containing creatine for treating and actively preventing dry skin and other negative alterations of the physiological homeostasis of healthy skin
Beiersdorf 1406599*
Compsns and methods of administering tubulin binding agents for the treatment of ocular diseases
Oxigene 1406600*
Pharmaceutical compsns for oral use, containing, in combination, metformin and glicazide, a sulphonyl urea
L Molteni & C dei Fratelli alitti Soceita' di Esercizio Societa' per Azioni 1406601*
Use of sulphonyl aryl or heteroaryl hydroxyamic acids and derivatives thereof as aggrecanase inhibitors
Pharmacia 1406602*
Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases
Transition Therapeutics 1406603*
Topical application of muscarinic analgesic drugs such as neostigmine
El Khoury, George 1406604*
Carbamates of 2-heterocyclic-1,2-ethanediols
SK Corp 1406605*
Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
Ortho-McNeil Pharmaceutical 1406606*
Nitrosated and nitrosylated nebivolol and metabolites, compsns and methods of use
Nitromed 1406608*
Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compsns and methods of use
Nitromed 1406609*
Use of substituted gamma-lactone compounds as medicaments
Gruenenthal 1406610*
Methods for treating fibrotic diseases or other indications
Alteon 1406611*
Use of a heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic dystamycin A for the treatment of beta-thalassaemia
Universita' Degli Studi di Ferrara; Associazione Veneta per la Lotta alla Talassemia; Associazione per la Lotta alla Talassemia di Ferrara 1406612*
Organic nitrate-based compounds for the treatment of vasculopathies
Nicox 1406613*
Carvediol polymorph
SmithKline Beecham 1406614*
Kinase inhibitors and the use thereof
Forschungszentrum Karlsruhe 1406615*
Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same
Steba Biotech 1406616*
Diaminediols for the treatment of Alzheimer's disease
Elan Pharmaceuticals 1406617*
Use of NK-1 receptor antagonists with pyridinic structure for the treatment of brain, spinal or nerve injury
F Hoffmann-La Roche 1406618*
Antiviral and antimicrobial guanidine or biguanidine derivatives
Shetty, B Vithal 1406619*
Vinyl phenyl derivatives as GLK activators
AstraZeneca 1406620*
Compsns and methods for inhibiting platelet activation and thrombosis
Beth Israel Deaconess Medical Centre 1406621*
Dipeptidyl peptidase inhibitors for the treatment of diabetes
Merck 1406622*
Substituted 1-phenethylpiperidine compounds used as inter alia analgesics
Gruenenthal 1406623*
Process for the preparation of paroxetine substantially free of alkoxy impurities
Teva Pharmaceuticals Industries; Teva Pharmaceutical USA 1406624*
A process for preparing paroxetine HCl which limits formation of pink coloured compounds
Teva Pharmaceutical Industries 1406625*
Sulphonyl aryl hydroxamates and their use as MMP inhibitors
Pharmacia Corp 1406626*
Pyridin-2-yl-methylamine derivatives for treating opioid dependence
Pierre Fabre Medicament 1406627*
Tetrahydroquinoline derivatives
Akzo Nobel 1406628*
Method for inducing analgesia comprising administration alternatively of an opioid receptor agonist and an opioid receptor like receptor 1 agonist for and an implantable infusion pump
Omeros Corp; The Regents of the University of California 1406629*
Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic
Endo Pharmaceuticals 1406630*
Dopamine receptor ligands and therapeutic methods based thereon
The Regents of the University of Michigan 1406631*
Substituted 3-aryl-5-aryl-1,2,4]-oxadiazoles and analogues as activators of caspases and inducers of apoptosis and the use thereof
Cytovia 1406632*
Enhanced drug delivery in transdermal systems
Noven Pharmaceuticals 1406633*
Combination of drospirenone and an estrogen sulphamate for HRT
Schering AG 1406634*
A controlled-release anti-inflammatory formulation and a process for the preparation thereof
Ajanta Pharma 1406635*
System and method for the large scale labelling of compounds with radiohalogens
The Univ. of Alabama, the Univ, of British Columbia, Carleton Univ, Simon Fraser Univ and the Univ of Victoria, collectively doing business as Triumf 1406636*
Pharmaceutical compsns with wound healing or anti-complementary activity comprising a dextran derivative
Biodex 1406637*
Macrophage receptor agonist or antagonist
Isis Innovation 1406638*
Method for enhancing the effectiveness of cancer therapies
Glycogenesys 1406639*
Use of glycosaminoglycans for the treatment of HIV-associated nephropathy
Keryx Biopharmaceuticals 1406640*
Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
Neptune Technologies 1406641*
Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections
Instytut Immunoligil I Terapil Doswiadczalnej-Pan 1406642*
Physiological tissue repair and functional organ regeneration by cultivation of regenerative stem cells in vivo and in situ
Xu, Rongxiang 1406643*
Modified proteins, designer toxins, and method of making thereof
Research Development Foundation 1406644*
Novel human transporter proteins and polynucleotides encoding the same
Lexicon Genetics 1406645*
Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
PE Corp 1406646*
Use of antimicrobial peptides as preservatives in ophthalmic preparations including solutions emulsions and suspensions
Allergan 1406647*
The use of angiotensis I derivative as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders
National University of Singapore 1406648*
Use of substances with oxytocin activity against climacteric disorders
EntreTech Medical 1406649*
Use of poly-glu, TYR and T cells treated therewith for neuroprotection therapy
Yeda Research and Development 1406650*
